In the ICU, every second is a race against death. And the stable operation of a therapeutic device is often the guarantee of life.

Since the launch of Respircare’s HUMID-B Series High Flow Humidified Therapy Devices in 2017, they have been successively installed in major hospitals and are used in departments such as ICU, Respiratory and Critical Care, and Neurosurgery in numerous tertiary hospitals. Some devices have been in continuous operation for over 30,000 hours, becoming the most trusted guardians for clinical medical staff.

 

Proof in Numbers, Backed by Strength

 

 

Respircare’s High Flow Humidified Respiratory Therapy Device B Series, with over 30,000 hours of real-world operational data, presents a solid performance record:

 

• 7×24 Continuous Operation: From severe pneumonia patients in the RICU, to hypoxemia alerts in the Post-Anesthesia Care Unit (PACU), and ARDS support in the Emergency Rescue Room, the B Series consistently operates at an ultra-quiet <20dB, ensuring no interference and unwavering reliability.

 

• Enduring Precision: The ultrasonic oxygen concentration sensor requires no maintenance or calibration. Even after 30,000 hours, the oxygen concentration display accuracy remains at ±3%, eliminating the risk of concentration drift caused by the degradation of traditional oxygen sensors.

 

• Stable and Consistent Heat & Humidity Output: With precise temperature control from 29°C to 37°C (adjustable degree by degree) and 7 levels of fine-tuned humidification intensity, the device provides individualized temperature and humidity requirements, reducing condensate in the circuit by over 80%.

 

Deconstructing the Technological Moat Behind “30,000 Hours”

 

1. Automatic Oxygen Control Algorithm
* The BH Series is equipped with the Auto-FiO₂ intelligent regulation system. When the flow rate is switched arbitrarily between 10-90 L/min, the system automatically corrects the oxygen concentration through linear compensation, ensuring the patient’s actual inhaled oxygen concentration is highly consistent with the set value.

 

2. 90 L/min Peak Flow to Meet Extreme Demands
* When a patient’s peak inspiratory flow rate soars to 120 L/min, traditional 60 L/min devices are often insufficient. The 90 L/min maximum output of Respircare’s BH90/BM90 models can control FiO₂ deviation within 5%, preserving “flow reserve” for critically ill patients.

 

3. Stable and Efficient Temperature & Humidity Output
* High-power Servo Temperature Control System: Enables rapid response of temperature and humidity under variable loads, resulting in more stable output.
* Wall-Adhering Heater Wire Circuit: Features an external ring heater wire design that adheres to the circuit wall, keeping the inner wall smooth to reduce resistance. This enhances the circuit’s heat retention, reducing condensate by 80%.

4. Strict Quality Control: From Components to the Complete Device
* Every detail is designed for clinical convenience—from the IPX1 drip-proof rating and BF-type electrical safety, to the lightweight 2.5kg body and a humidification chamber with a capacity of ≥90 mL.

 

Endorsed by Authority: From Consensus to Manual

 

 

Respircare Medical is not just a product provider but also a shaper of industry standards:

• Participated in formulating the Expert Consensus on the Standardized Clinical Application of Adult Nasal High Flow Humidified Oxygen Therapy.

• Co-published the Practical Handbook of High Flow Oxygen Therapy (jointly released with the authority of the Chinese Medical Association).

Return